We are live on ! Find out more
ANAB icon

AnaptysBio

124 hedge funds and large institutions have $633M invested in AnaptysBio in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,356% more call options, than puts

Call options by funds: $5.03M | Put options by funds: $205K

3.25% more ownership

Funds ownership: 107.31%110.55% (+3.2%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 39

5% less funds holding

Funds holding: 131124 (-7)

14% less capital invested

Capital invested by funds: $733M → $633M (-$100M)

14% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 21

Holders
124
Holders Change
-7
Holders Change %
-5.34%
% of All Funds
2.09%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
18
Increased
39
Reduced
39
Closed
21
Calls
$5.03M
Puts
$205K
Net Calls
+$4.83M
Net Calls Change
+$4.47M
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
$694K +$524K +23,677 +226%
Citadel Advisors
52
Citadel Advisors
Florida
$686K +$555K +25,059 +288%
HS
53
HighVista Strategies
Massachusetts
$672K +$423K +19,105 +136%
AllianceBernstein
54
AllianceBernstein
Tennessee
$662K +$90.8K +4,100 +14%
RhumbLine Advisers
55
RhumbLine Advisers
Massachusetts
$621K +$108K +4,895 +19%
Millennium Management
56
Millennium Management
New York
$615K +$671K +30,286 New
Renaissance Technologies
57
Renaissance Technologies
New York
$601K -$636K -28,700 -49%
SG Americas Securities
58
SG Americas Securities
New York
$515K +$562K +25,374 New
MAM
59
Martingale Asset Management
Massachusetts
$480K +$24.4K +1,101 +5%
ZCM
60
Ziegler Capital Management
Illinois
$475K +$13.8K +624 +3%
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$462K -$17K -767 -3%
UBS Group
62
UBS Group
Switzerland
$449K -$572K -25,816 -54%
Los Angeles Capital Management
63
Los Angeles Capital Management
California
$422K -$1.88M -84,828 -80%
Principal Financial Group
64
Principal Financial Group
Iowa
$393K +$89.2K +4,029 +26%
State of Wisconsin Investment Board
65
State of Wisconsin Investment Board
Wisconsin
$384K -$219K -9,900 -34%
Invesco
66
Invesco
Georgia
$384K +$49.9K +2,251 +13%
Russell Investments Group
67
Russell Investments Group
United Kingdom
$349K +$997 +45 +0.3%
Two Sigma Investments
68
Two Sigma Investments
New York
$340K -$586K -26,449 -61%
Victory Capital Management
69
Victory Capital Management
Texas
$340K -$57K -2,572 -13%
AA
70
ALPS Advisors
Colorado
$339K -$260K -11,718 -41%
Wellington Management Group
71
Wellington Management Group
Massachusetts
$339K
JF
72
Jump Financial
Illinois
$313K +$342K +15,425 New
Jacobs Levy Equity Management
73
Jacobs Levy Equity Management
New Jersey
$308K -$2.13M -96,211 -86%
UBS AM
74
UBS AM
Illinois
$297K -$185K -8,361 -36%
E
75
Ergoteles
New York
$283K -$119K -5,392 -28%

ANAB Hedge Fund Activity: Q2 2022 in Review

124 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q2 2022, worth a combined $633M — down 14% from $733M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ANAB and 18 opened new positions — a net loss of 3 holders — while 39 trimmed existing stakes and 39 added.

The largest buyer was Deerfield Management, opening a new position worth an estimated $17.1M. The largest seller was Point72 Asset Management, cutting an estimated $10.3M.

  • 124 institutional investors held AnaptysBio (ANAB) as of Q2 2022, down from 131 in Q1 2022.
  • Funds reported $633M of AnaptysBio stock for Q2 2022, down 14% quarter-over-quarter.
  • 18 funds opened new AnaptysBio positions in Q2 2022 and 21 closed out, a net change of -3 holders.
  • The largest AnaptysBio buyer in Q2 2022 was Deerfield Management, an estimated $17.1M added.
  • The largest AnaptysBio seller in Q2 2022 was Point72 Asset Management, an estimated $10.3M sold.

Based on aggregated 13F filings for Q2 2022.